Inventor · disambiguated record
Sam Philip Heywood
Also filed as: HEYWOOD SAM P · HEYWOOD SAM PHILIP
24 granted patents·8 pending applications·142 citations·filing 2004–2022
95Inventor score
Top patents by PatentIndex Score
32 records- 0194US9873735B2Method of treatment with antibodies having specificity for human OX40UCB BIOPHARMA SPRL·Filed 2015·Granted Jan 23, 2018·12 cites·50 claims
- 0294US9309327B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2013·Granted Apr 12, 2016·32 cites·7 claims
- 0394US9040048B2Antibody molecules having specificity for human OX40UCB PHARMA SA·Filed 2012·Granted May 26, 2015·19 cites·11 claims
- 0491US8629246B2Dual specificity antibody fusionsHUMPHREYS DAVID PAUL·Filed 2008·Granted Jan 14, 2014·21 cites·8 claims
- 0590US8378073B2Process for attaching effector molecules to proteinsUCB PHARMA SA·Filed 2006·Granted Feb 19, 2013·10 cites·21 claims
- 0689US9828438B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2016·Granted Nov 28, 2017·7 cites·8 claims
- 0788US9803004B2Albumin binding antibodies and binding fragments thereofUCB BIOPHARMA SPRL·Filed 2012·Granted Oct 31, 2017·10 cites·11 claims
- 0887US10100130B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2017·Granted Oct 16, 2018·5 cites·11 claims
- 0985US10829565B2Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric speciesUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 10, 2020·5 cites·22 claims
- 1084US10828366B2Method of monomerisation of recombinant antibody moleculesUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 10, 2020·4 cites·15 claims
- 1182US10023631B2Albumin binding antibodies and binding fragments thereofUCB BIOPHARMA SPRL·Filed 2017·Granted Jul 17, 2018·3 cites·3 claims
- 1277US10457748B2Single linker FabFv antibodies and methods of producing sameUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 29, 2019·3 cites·24 claims
- 1374US10407513B2Biological productsADAMS RALPH·Filed 2009·Granted Sep 10, 2019·3 cites·8 claims
- 1473US12428497B2Multispecific antibody constructsUCB Biopharma SRL·Filed 2022·Granted Sep 30, 2025·0 cites·23 claims
- 1572US7989594B2Modified antibody fab fragmentsUCB PHARMA SA·Filed 2004·Granted Aug 2, 2011·5 cites·16 claims
- 1671US11345760B2Multispecific antibody constructsUCB Biopharma SRL·Filed 2015·Granted May 31, 2022·1 cites·26 claims
- 1770US10927164B2Method for protein purificationUCB Biopharma SRL·Filed 2016·Granted Feb 23, 2021·1 cites·15 claims
- 1867US11427650B2Dual specificity antibody fusionsUCB PHARMA SA·Filed 2019·Granted Aug 30, 2022·0 cites·12 claims
- 1967US10472426B2Disulfide stabilized DVD-Ig moleculesHEYWOOD SAM PHILIP·Filed 2011·Granted Nov 12, 2019·1 cites·6 claims
- 2062US11834514B2Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric speciesUCB Biopharma SRL·Filed 2020·Granted Dec 5, 2023·0 cites·20 claims
- 2161US11786593B2Method of monomerisation of recombinant antibody moleculesUCB Biopharma SRL·Filed 2020·Granted Oct 17, 2023·0 cites·15 claims
- 2255US11401349B2Single linker FabFv antibodies and methods of producing sameUCB BIOPHARMA SPRL·Filed 2019·Granted Aug 2, 2022·0 cites·28 claims
- 2354US2007059301A1Modified antibody fragmentsCILLTECH R & D LTD·Filed 2004·Application pending·0 cites
- 2449US11091542B2Antibody molecules which bind TNF alphaUCB Biopharma SRL·Filed 2016·Granted Aug 17, 2021·0 cites·22 claims
- 2548US11466076B2Binding domain or antibody specific to a human serum albumin (HSA)UCB BIOPHARMA SPRL·Filed 2017·Granted Oct 11, 2022·0 cites·12 claims
- 2648US2020048372A1Biological ProductsUCB PHARMA SA·Filed 2019·Application pending·0 cites
- 2747US2007014802A1Modified antibody fragmentsCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 2847US2023242677A1Multi-specific antibodiesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2942US2018127498A1Anti-fcrn antibodiesUCB BIOPHARMA SPRL·Filed 2016·Application pending·0 cites
- 3039US2013066054A1Multivalent antibodiesHUMPHREYS DAVID PAUL·Filed 2010·Application pending·0 cites
- 3138US2020277366A1MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17FUCB BIOPHRMA SPRL·Filed 2016·Application pending·0 cites
- 3236US2017198062A1Multi-specific antibody constructsBHATTA PALLAVI·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sam Philip Heywood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →